(Total Views: 584)
Posted On: 04/06/2020 4:58:18 PM
Post# of 157019
Quote:
If IMMu's drug posts a 40% response rate (which would assure approval), and Leronlimab achieves a response rate of >80
Even if the response rates are equal, that sacituzumab govitecan is third line tells me the side effects must be awful.
(1)
(0)
